Sight Sciences (SGHT) Shareholder's Equity Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Sight Sciences | 247.60 Mn | 162.64 Mn | 16.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.56% |
| Dec 31, 2025 | -26.94% |
| Sep 30, 2025 | -32.30% |
| Jun 30, 2025 | -31.12% |
| Mar 31, 2025 | -28.92% |
| Dec 31, 2024 | -27.19% |
| Sep 30, 2024 | -25.27% |
| Jun 30, 2024 | -25.34% |
| Mar 31, 2024 | -25.39% |
| Dec 31, 2023 | -24.90% |
| Sep 30, 2023 | -26.52% |
| Jun 30, 2023 | -29.01% |
| Mar 31, 2023 | -30.93% |
| Dec 31, 2022 | -31.03% |
| Sep 30, 2022 | 170.31% |
| Jun 30, 2022 | 263.49% |
| Mar 31, 2022 | 310.23% |
| Dec 31, 2021 | 361.24% |
| Sep 30, 2021 | -207.62% |
| Jun 30, 2021 | -62.81% |